phase,status,disease_id,disease_name,chembl_id,drug_name,gene_symbol,smiles
4.0,,EFO_0000540,immune system disease,CHEMBL2108730,SARILUMAB,IL6R,
4.0,,EFO_0000540,immune system disease,CHEMBL3833307,SATRALIZUMAB,IL6R,
4.0,,EFO_0000540,immune system disease,CHEMBL1237022,TOCILIZUMAB,IL6R,
3.0,"Active, not recruiting",EFO_0000685,rheumatoid arthritis,CHEMBL4650406,LEVILIMAB,IL6R,
2.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL3833343,VOBARILIZUMAB,IL6R,
4.0,,EFO_0000274,atopic eczema,CHEMBL1201109,DESONIDE,NR3C1,CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
4.0,,EFO_0000274,atopic eczema,CHEMBL131,PREDNISOLONE,NR3C1,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO
4.0,,EFO_0000274,atopic eczema,CHEMBL1473,FLUTICASONE PROPIONATE,NR3C1,CCC(=O)O[C@]1(C(=O)SCF)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
4.0,,EFO_0000274,atopic eczema,CHEMBL1650,CORTISONE ACETATE,NR3C1,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@@]21C
4.0,,EFO_0000274,atopic eczema,CHEMBL1683,HYDROCORTISONE BUTYRATE,NR3C1,CCCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
4.0,,EFO_0000274,atopic eczema,CHEMBL389621,HYDROCORTISONE,NR3C1,C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO
4.0,,EFO_0000274,atopic eczema,CHEMBL635,PREDNISONE,NR3C1,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO
4.0,,EFO_0000274,atopic eczema,CHEMBL650,METHYLPREDNISOLONE,NR3C1,C[C@H]1C[C@@H]2[C@H]([C@@H](O)C[C@@]3(C)[C@H]2CC[C@]3(O)C(=O)CO)[C@@]2(C)C=CC(=O)C=C12
4.0,,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL1201014,PREDNISOLONE SODIUM PHOSPHATE,NR3C1,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COP(=O)([O-])[O-].[Na+].[Na+]
4.0,,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL1370,BUDESONIDE,NR3C1,CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
4.0,,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL1676,FLUTICASONE FUROATE,NR3C1,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)SCF
4.0,,EFO_0000274,atopic eczema,CHEMBL2021430,DEXAMETHASONE SODIUM PHOSPHATE,NR3C1,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)([O-])[O-].[Na+].[Na+]
4.0,,EFO_0000274,atopic eczema,CHEMBL384467,DEXAMETHASONE,NR3C1,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
4.0,,EFO_0000274,atopic eczema,CHEMBL989,FLUOCINOLONE ACETONIDE,NR3C1,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
4.0,,EFO_0000544,infection,CHEMBL1200384,BETAMETHASONE DIPROPIONATE,NR3C1,CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
4.0,,EFO_0000546,injury,CHEMBL1504,TRIAMCINOLONE ACETONIDE,NR3C1,CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
4.0,,EFO_0000574,lymphoma,CHEMBL1201081,METHYLPREDNISOLONE SODIUM SUCCINATE,NR3C1,C[C@H]1C[C@@H]2[C@H]([C@@H](O)C[C@@]3(C)[C@H]2CC[C@]3(O)C(=O)COC(=O)CCC(=O)[O-])[C@@]2(C)C=CC(=O)C=C12.[Na+]
4.0,,EFO_0000565,leukemia,CHEMBL1364144,METHYLPREDNISOLONE ACETATE,NR3C1,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
4.0,,EFO_0000676,psoriasis,CHEMBL1766,DESOXIMETASONE,NR3C1,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO
4.0,,EFO_0000676,psoriasis,CHEMBL1159650,CLOBETASOL PROPIONATE,NR3C1,CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
4.0,Terminated,EFO_0000676,psoriasis,CHEMBL1200908,HALOBETASOL PROPIONATE,NR3C1,CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
4.0,,EFO_0000701,skin disease,CHEMBL1091,HYDROCORTISONE ACETATE,NR3C1,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
4.0,,EFO_0000701,skin disease,CHEMBL1200386,PREDNICARBATE,NR3C1,CCOC(=O)O[C@]1(C(=O)COC(=O)CC)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
4.0,,EFO_0000701,skin disease,CHEMBL1200545,DIFLORASONE DIACETATE,NR3C1,CC(=O)OCC(=O)[C@@]1(OC(C)=O)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
4.0,,EFO_0000701,skin disease,CHEMBL1200953,HYDROCORTISONE PROBUTATE,NR3C1,CCCC(=O)O[C@]1(C(=O)COC(=O)CC)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
4.0,,EFO_0000701,skin disease,CHEMBL1200989,ALCLOMETASONE DIPROPIONATE,NR3C1,CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@H](C)C[C@H]2[C@H]3[C@H]([C@@H](O)C[C@@]21C)[C@@]1(C)C=CC(=O)C=C1C[C@H]3Cl
4.0,,EFO_0000701,skin disease,CHEMBL1497,BETAMETHASONE VALERATE,NR3C1,CCCCC(=O)O[C@]1(C(=O)CO)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
4.0,,EFO_0000701,skin disease,CHEMBL1501,FLUOCINONIDE,NR3C1,CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C
4.0,,EFO_0000701,skin disease,CHEMBL1161,MOMETASONE FUROATE,NR3C1,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl
4.0,,EFO_0000701,skin disease,CHEMBL1200845,HALCINONIDE,NR3C1,CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CCl)O1
4.0,,EFO_0000701,skin disease,CHEMBL1201012,FLURANDRENOLIDE,NR3C1,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
4.0,,EFO_0000701,skin disease,CHEMBL1451,TRIAMCINOLONE,NR3C1,C[C@]12C=CC(=O)C=C1CC[C@H]1[C@@H]3C[C@@H](O)[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@]12F
4.0,,EFO_0000729,ulcerative colitis,CHEMBL1200538,BETAMETHASONE ACETATE,NR3C1,CC(=O)OCC(=O)[C@@]1(O)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
4.0,,EFO_0000729,ulcerative colitis,CHEMBL1200762,BETAMETHASONE SODIUM PHOSPHATE,NR3C1,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)([O-])[O-].[Na+].[Na+]
4.0,,EFO_0003099,Cushing syndrome,CHEMBL1276308,MIFEPRISTONE,NR3C1,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C
4.0,,EFO_0003894,acne,CHEMBL1200600,FLUOROMETHOLONE,NR3C1,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
4.0,,EFO_0005752,eye inflammation,CHEMBL1200617,RIMEXOLONE,NR3C1,CCC(=O)[C@@]1(C)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
4.0,,EFO_0005752,eye inflammation,CHEMBL1201173,MEDRYSONE,NR3C1,CC(=O)[C@H]1CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C
4.0,,EFO_0005752,eye inflammation,CHEMBL632,BETAMETHASONE,NR3C1,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
4.0,,EFO_0007141,allergic conjunctivitis,CHEMBL1200865,LOTEPREDNOL ETABONATE,NR3C1,CCOC(=O)O[C@]1(C(=O)OCCl)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
4.0,Completed,EFO_0003956,seasonal allergic rhinitis,CHEMBL1200500,BECLOMETHASONE DIPROPIONATE,NR3C1,CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@@]21C
4.0,,EFO_0003956,seasonal allergic rhinitis,CHEMBL2040682,CICLESONIDE,NR3C1,CC(C)C(=O)OCC(=O)[C@@]12O[C@H](C3CCCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C
4.0,,EFO_1000811,anterior uveitis,CHEMBL1201749,DIFLUPREDNATE,NR3C1,CCCC(=O)O[C@]1(C(=O)COC(C)=O)CC[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
4.0,,EFO_0007141,allergic conjunctivitis,CHEMBL1152,PREDNISOLONE ACETATE,NR3C1,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
4.0,,EFO_0008521,rhinitis,CHEMBL1512,FLUNISOLIDE,NR3C1,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
4.0,,MONDO_0004979,asthma,CHEMBL1200495,HYDROCORTISONE SODIUM SUCCINATE,NR3C1,C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COC(=O)CCC(=O)[O-].[Na+]
4.0,Unknown status,MONDO_0005178,osteoarthritis,CHEMBL1200878,TRIAMCINOLONE HEXACETONIDE,NR3C1,CC(C)(C)CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL1201891,DEFLAZACORT,NR3C1,CC(=O)OCC(=O)[C@@]12N=C(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL3707311,VAMOROLONE,NR3C1,
3.0,Terminated,EFO_0000222,acute myeloid leukemia,CHEMBL1201265,METHYLPREDNISOLONE HEMISUCCINATE,NR3C1,C[C@H]1C[C@@H]2[C@H]([C@@H](O)C[C@@]3(C)[C@H]2CC[C@]3(O)C(=O)COC(=O)CCC(=O)O)[C@@]2(C)C=CC(=O)C=C12
3.0,Unknown status,EFO_0000565,leukemia,CHEMBL1530428,DEXAMETHASONE ACETATE,NR3C1,CC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
3.0,Completed,EFO_0000673,prostate adenocarcinoma,CHEMBL139835,CYPROTERONE ACETATE,NR3C1,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C
3.0,Completed,EFO_0003099,Cushing syndrome,CHEMBL4068611,RELACORILANT,NR3C1,Cn1cc(S(=O)(=O)N2CCC3=Cc4c(cnn4-c4ccc(F)cc4)C[C@]3(C(=O)c3cc(C(F)(F)F)ccn3)C2)cn1
3.0,Completed,EFO_0006834,septic shock,CHEMBL977,HYDROCORTISONE HEMISUCCINATE ANHYDROUS,NR3C1,C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COC(=O)CCC(=O)O
3.0,Completed,EFO_1000811,anterior uveitis,CHEMBL1201302,DEXAMETHASONE PHOSPHORIC ACID,NR3C1,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O
3.0,Unknown status,EFO_0007308,Herpes simplex virus keratitis,CHEMBL1201231,PREDNISOLONE PHOSPHORIC ACID,NR3C1,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COP(=O)(O)O
3.0,Terminated,EFO_1001097,periarthritis,CHEMBL1201207,BETAMETHASONE PHOSPHORIC ACID,NR3C1,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O
3.0,Completed,MONDO_0005129,cataract,CHEMBL2103876,MAPRACORAT,NR3C1,Cc1ccc2c(NC[C@](O)(CC(C)(C)c3cc(F)cc4c3OCC4)C(F)(F)F)cccc2n1
2.0,Completed,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL4072756,AZD-5423,NR3C1,COc1cccc([C@@H](Oc2ccc3c(cnn3-c3ccc(F)cc3)c2)[C@H](C)NC(=O)C(F)(F)F)c1
2.0,Completed,EFO_0000677,mental or behavioural disorder,CHEMBL3545391,ORG-34517,NR3C1,CC#C[C@]1(O)CCC2C3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc4c(c3)OCO4)C[C@@]21C
2.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL4297572,ABBV-3373,NR3C1,
2.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL3137316,FOSDAGROCORAT,NR3C1,Cc1ncccc1NC(=O)c1ccc2c(c1)CC[C@@H]1C[C@@](OP(=O)(O)O)(C(F)(F)F)CC[C@@]21Cc1ccccc1
2.0,Completed,EFO_0000756,melanoma,CHEMBL1201148,MEPREDNISONE,NR3C1,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3C(=O)C[C@]2(C)[C@@]1(O)C(=O)CO
2.0,Completed,EFO_0003843,pain,CHEMBL2105842,CORTIVAZOL,NR3C1,CC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3C=C(C)C4=Cc5c(cnn5-c5ccccc5)C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
2.0,Completed,MONDO_0004979,asthma,CHEMBL3666807,VELSECORAT,NR3C1,C[C@H](NC(=O)C(C)(F)F)[C@H](Oc1ccc2c(cnn2-c2cccc(C(=O)N[C@@H]3CCOC3)c2)c1)c1ccc2c(c1)OCCO2
2.0,Completed,MONDO_0015129,chronic primary adrenal insufficiency,CHEMBL1549,HYDROCORTISONE CYPIONATE,NR3C1,C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COC(=O)CCC1CCCC1
4.0,Completed,EFO_0000384,Crohn's disease,CHEMBL1201580,ADALIMUMAB,TNF,
4.0,,EFO_0000384,Crohn's disease,CHEMBL1201581,INFLIXIMAB,TNF,
4.0,,EFO_0000384,Crohn's disease,CHEMBL1201831,CERTOLIZUMAB PEGOL,TNF,
4.0,,EFO_0000540,immune system disease,CHEMBL1201572,ETANERCEPT,TNF,
4.0,,EFO_0000540,immune system disease,CHEMBL1201833,GOLIMUMAB,TNF,
3.0,Terminated,EFO_0003778,psoriatic arthritis,CHEMBL2107911,ONERCEPT,TNF,
2.0,,EFO_0000540,immune system disease,CHEMBL2108887,AFELIMOMAB,TNF,
2.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL1743057,PEGSUNERCEPT,TNF,
2.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL4297572,ABBV-3373,TNF,
2.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL1743054,OZORALIZUMAB,TNF,
2.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL2108739,PLACULUMAB,TNF,
2.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL4297863,REMTOLUMAB,TNF,
4.0,,EFO_0000319,cardiovascular disease,CHEMBL521,IBUPROFEN,PTGS2,CC(C)Cc1ccc(C(C)C(=O)O)cc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL6,INDOMETHACIN,PTGS2,COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1
4.0,Completed,EFO_0000612,myocardial infarction,CHEMBL25,ASPIRIN,PTGS2,CC(=O)Oc1ccccc1C(=O)O
4.0,,EFO_0000616,neoplasm,CHEMBL118,CELECOXIB,PTGS2,Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL1034,DICLOFENAC SODIUM,PTGS2,O=C([O-])Cc1ccccc1Nc1c(Cl)cccc1Cl.[Na+]
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL1070,NABUMETONE,PTGS2,COc1ccc2cc(CCC(C)=O)ccc2c1
4.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL1200804,DICLOFENAC POTASSIUM,PTGS2,O=C([O-])Cc1ccccc1Nc1c(Cl)cccc1Cl.[K+]
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL139,DICLOFENAC,PTGS2,O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL154,NAPROXEN,PTGS2,COc1ccc2cc([C@H](C)C(=O)O)ccc2c1
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL1562610,MECLOFENAMATE SODIUM,PTGS2,Cc1ccc(Cl)c(Nc2ccccc2C(=O)[O-])c1Cl.O.[Na+]
4.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL421,SULFASALAZINE,PTGS2,O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL599,MELOXICAM,PTGS2,Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL865,VALDECOXIB,PTGS2,Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1
4.0,,EFO_0000729,ulcerative colitis,CHEMBL1200760,BALSALAZIDE DISODIUM,PTGS2,O=C([O-])CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)[O-])c2)cc1.[Na+].[Na+]
4.0,,EFO_0000729,ulcerative colitis,CHEMBL1201013,OLSALAZINE SODIUM,PTGS2,O=C([O-])c1cc(/N=N/c2ccc(O)c(C(=O)[O-])c2)ccc1O.[Na+].[Na+]
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL1071,OXAPROZIN,PTGS2,O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1
4.0,,EFO_0000729,ulcerative colitis,CHEMBL704,MESALAMINE,PTGS2,Nc1ccc(O)c(C(=O)O)c1
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL1200613,TOLMETIN SODIUM,PTGS2,Cc1ccc(C(=O)c2ccc(CC(=O)[O-])n2C)cc1.[Na+]
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL1200806,NAPROXEN SODIUM,PTGS2,COc1ccc2cc([C@H](C)C(=O)[O-])ccc2c1.[Na+]
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL15770,SULINDAC,PTGS2,CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc([S+](C)[O-])cc1
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL2103736,FENOPROFEN CALCIUM,PTGS2,CC(C(=O)[O-])c1cccc(Oc2ccccc2)c1.CC(C(=O)[O-])c1cccc(Oc2ccccc2)c1.O.O.[Ca+2]
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL527,PIROXICAM,PTGS2,CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL571,KETOPROFEN,PTGS2,CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL622,ETODOLAC,PTGS2,CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)O)OCC3
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL898,DIFLUNISAL,PTGS2,O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL93645,ACECLOFENAC,PTGS2,O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl
4.0,,EFO_0003843,pain,CHEMBL1021,NEPAFENAC,PTGS2,NC(=O)Cc1cccc(C(=O)c2ccccc2)c1N
4.0,,EFO_0003843,pain,CHEMBL112,ACETAMINOPHEN,PTGS2,CC(=O)Nc1ccc(O)cc1
4.0,,EFO_0003843,pain,CHEMBL1201180,DICLOFENAC EPOLAMINE,PTGS2,O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl.OCCN1CCCC1
4.0,,EFO_0003843,pain,CHEMBL146095,GLAFENINE,PTGS2,O=C(OCC(O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12
4.0,Completed,EFO_0003843,pain,CHEMBL3989803,DIPYRONE,PTGS2,Cc1c(N(C)CS(=O)(=O)[O-])c(=O)n(-c2ccccc2)n1C.O.[Na+]
4.0,,EFO_0005752,eye inflammation,CHEMBL1077,BROMFENAC,PTGS2,Nc1c(CC(=O)O)cccc1C(=O)c1ccc(Br)cc1
4.0,,EFO_0005752,eye inflammation,CHEMBL3989676,OXYPHENBUTAZONE,PTGS2,CCCCC1C(=O)N(c2ccccc2)N(c2ccc(O)cc2)C1=O.O
4.0,,EFO_0005752,eye inflammation,CHEMBL469,KETOROLAC,PTGS2,O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O
4.0,,EFO_0005752,eye inflammation,CHEMBL563,FLURBIPROFEN,PTGS2,CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1
4.0,,EFO_0005755,rheumatic disease,CHEMBL101,PHENYLBUTAZONE,PTGS2,CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O
4.0,,EFO_0005755,rheumatic disease,CHEMBL122,ROFECOXIB,PTGS2,CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1
4.0,,EFO_0005755,rheumatic disease,CHEMBL12610,BENZYDAMINE,PTGS2,CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12
4.0,,EFO_0005755,rheumatic disease,CHEMBL1297,FENOPROFEN,PTGS2,CC(C(=O)O)c1cccc(Oc2ccccc2)c1
4.0,,EFO_0005755,rheumatic disease,CHEMBL15870,INDOPROFEN,PTGS2,CC(C(=O)O)c1ccc(N2Cc3ccccc3C2=O)cc1
4.0,,EFO_0005755,rheumatic disease,CHEMBL175,DEXIBUPROFEN,PTGS2,CC(C)Cc1ccc([C@H](C)C(=O)O)cc1
4.0,,EFO_0005755,rheumatic disease,CHEMBL189171,ACEMETACIN,PTGS2,COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1
4.0,,EFO_0005755,rheumatic disease,CHEMBL416146,ETORICOXIB,PTGS2,Cc1ccc(-c2ncc(Cl)cc2-c2ccc(S(C)(=O)=O)cc2)cn1
4.0,,EFO_0005755,rheumatic disease,CHEMBL686,MEFENAMIC ACID,PTGS2,Cc1cccc(Nc2ccccc2C(=O)O)c1C
4.0,,EFO_0005755,rheumatic disease,CHEMBL75435,DEXKETOPROFEN,PTGS2,C[C@H](C(=O)O)c1cccc(C(=O)c2ccccc2)c1
4.0,,EFO_0003843,pain,CHEMBL1201124,KETOROLAC TROMETHAMINE,PTGS2,NC(CO)(CO)CO.O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O
4.0,,EFO_0003843,pain,CHEMBL2108222,ALOXIPRIN,PTGS2,
4.0,,EFO_0003843,pain,CHEMBL296913,PARECOXIB SODIUM,PTGS2,CCC(=O)[N-]S(=O)(=O)c1ccc(-c2c(-c3ccccc3)noc2C)cc1.[Na+]
4.0,,EFO_0003843,pain,CHEMBL3181947,BROMFENAC SODIUM,PTGS2,Nc1c(CC(=O)[O-])cccc1C(=O)c1ccc(Br)cc1.Nc1c(CC(=O)[O-])cccc1C(=O)c1ccc(Br)cc1.O.O.O.[Na+].[Na+]
4.0,,EFO_0005755,rheumatic disease,CHEMBL1020,TOLMETIN,PTGS2,Cc1ccc(C(=O)c2ccc(CC(=O)O)n2C)cc1
4.0,,EFO_0005755,rheumatic disease,CHEMBL1206690,PARECOXIB,PTGS2,CCC(=O)NS(=O)(=O)c1ccc(-c2c(-c3ccccc3)noc2C)cc1
4.0,,EFO_0005755,rheumatic disease,CHEMBL1565476,APAZONE,PTGS2,CCCC1C(=O)N2C(N(C)C)=Nc3ccc(C)cc3N2C1=O
4.0,,EFO_0005755,rheumatic disease,CHEMBL1569487,LORNOXICAM,PTGS2,CN1C(C(=O)Nc2ccccn2)=C(O)c2sc(Cl)cc2S1(=O)=O
4.0,,EFO_0005755,rheumatic disease,CHEMBL188952,PIRPROFEN,PTGS2,CC(C(=O)O)c1ccc(N2CC=CC2)c(Cl)c1
4.0,,EFO_0005755,rheumatic disease,CHEMBL404108,LUMIRACOXIB,PTGS2,Cc1ccc(Nc2c(F)cccc2Cl)c(CC(=O)O)c1
4.0,,EFO_0005755,rheumatic disease,CHEMBL509,MECLOFENAMIC ACID,PTGS2,Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl
4.0,,EFO_0005755,rheumatic disease,CHEMBL956,SUPROFEN,PTGS2,CC(C(=O)O)c1ccc(C(=O)c2cccs2)cc1
4.0,,HP_0002018,Nausea,CHEMBL1120,BISMUTH SUBSALICYLATE,PTGS2,
4.0,,HP_0001643,Patent ductus arteriosus,CHEMBL1201141,IBUPROFEN LYSINE,PTGS2,CC(C)Cc1ccc(C(C)C(=O)O)cc1.NCCCC[C@H](N)C(=O)O
3.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL2107455,IGURATIMOD,PTGS2,CS(=O)(=O)Nc1cc2occ(NC=O)c(=O)c2cc1Oc1ccccc1
3.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL364804,GW-406381,PTGS2,CCOc1ccc(-c2nn3ncccc3c2-c2ccc(S(C)(=O)=O)cc2)cc1
3.0,Completed,EFO_0000729,ulcerative colitis,CHEMBL1201346,BALSALAZIDE,PTGS2,O=C(O)CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)O)c2)cc1
3.0,Completed,EFO_0003843,pain,CHEMBL3989408,IBUPROFEN SODIUM,PTGS2,CC(C)Cc1ccc(C(C)C(=O)[O-])cc1.O.O.[Na+]
3.0,Recruiting,EFO_0003843,pain,CHEMBL461522,METAMIZOLE,PTGS2,Cc1c(N(C)CS(=O)(=O)O)c(=O)n(-c2ccccc2)n1C
3.0,,EFO_0005755,rheumatic disease,CHEMBL2103831,NAPROXCINOD,PTGS2,COc1ccc2cc([C@H](C)C(=O)OCCCCO[N+](=O)[O-])ccc2c1
3.0,Completed,EFO_0003843,pain,CHEMBL19299,LOXOPROFEN,PTGS2,CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1
3.0,Completed,EFO_1000786,"osteoarthritis, hip",CHEMBL166863,POLMACOXIB,PTGS2,CC1(C)OC(c2ccc(S(N)(=O)=O)cc2)=C(c2cccc(F)c2)C1=O
3.0,Not yet recruiting,EFO_1001904,oral mucositis,CHEMBL1528134,BENZYDAMINE HYDROCHLORIDE,PTGS2,CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12.Cl
3.0,Completed,HP_0030839,Knee pain,CHEMBL435298,ESFLURBIPROFEN,PTGS2,C[C@H](C(=O)O)c1ccc(-c2ccccc2)c(F)c1
2.0,Completed,EFO_0002618,pancreatic carcinoma,CHEMBL1835207,APRICOXIB,PTGS2,CCOc1ccc(-c2cc(C)cn2-c2ccc(S(N)(=O)=O)cc2)cc1
2.0,Completed,EFO_0003898,ankylosing spondylitis,CHEMBL425,OLSALAZINE,PTGS2,O=C(O)c1cc(/N=N/c2ccc(O)c(C(=O)O)c2)ccc1O
2.0,Completed,MONDO_0002050,depressive disorder,CHEMBL435381,CIMICOXIB,PTGS2,COc1ccc(-c2c(Cl)ncn2-c2ccc(S(N)(=O)=O)cc2)cc1F
2.0,Completed,MONDO_0005178,osteoarthritis,CHEMBL2105683,NAPROXEN ETEMESIL,PTGS2,COc1ccc2cc([C@H](C)C(=O)OCCS(C)(=O)=O)ccc2c1
1.0,Completed,MP_0001845,inflammation,CHEMBL3989410,INDOMETHACIN SODIUM,PTGS2,COc1ccc2c(c1)c(CC(=O)[O-])c(C)n2C(=O)c1ccc(Cl)cc1.O.O.O.[Na+]
4.0,,EFO_0000095,chronic lymphocytic leukemia,CHEMBL1873475,IBRUTINIB,BTK,C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1
4.0,,EFO_0000095,chronic lymphocytic leukemia,CHEMBL3707348,ACALABRUTINIB,BTK,CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12
4.0,,EFO_0000095,chronic lymphocytic leukemia,CHEMBL4594293,ACALABRUTINIB MALEATE,BTK,CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12.O=C(O)/C=C\C(=O)O
4.0,,EFO_0000616,neoplasm,CHEMBL3936761,ZANUBRUTINIB,BTK,C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1
4.0,,EFO_0004192,alopecia areata,CHEMBL5314649,RITLECITINIB TOSYLATE,BTK,C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C.Cc1ccc(S(=O)(=O)O)cc1
4.0,,EFO_1001469,Mantle cell lymphoma,CHEMBL4650485,PIRTOBRUTINIB,BTK,COc1ccc(F)cc1C(=O)NCc1ccc(-c2nn([C@@H](C)C(F)(F)F)c(N)c2C(N)=O)cc1
3.0,Recruiting,EFO_0000095,chronic lymphocytic leukemia,CHEMBL4650321,ORELABRUTINIB,BTK,C=CC(=O)N1CCC(c2ccc(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)n2)CC1
3.0,"Active, not recruiting",EFO_0003840,chronic progressive multiple sclerosis,CHEMBL4065122,FENEBRUTINIB,BTK,C[C@H]1CN(C2COC2)CCN1c1ccc(Nc2cc(-c3ccnc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)nc1
3.0,Not yet recruiting,EFO_0003060,non-small cell lung carcinoma,CHEMBL4297865,ABIVERTINIB,BTK,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)nc3[nH]ccc23)c1
3.0,Recruiting,EFO_0004208,Vitiligo,CHEMBL4085457,RITLECITINIB,BTK,C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C
3.0,Not yet recruiting,EFO_0003060,non-small cell lung carcinoma,CHEMBL4297866,ABIVERTINIB MALEATE,BTK,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)nc3[nH]ccc23)c1.O.O.O=C(O)/C=C\C(=O)O
3.0,Recruiting,EFO_0008520,primary progressive multiple sclerosis,CHEMBL4650323,TOLEBRUTINIB,BTK,C=CC(=O)N1CCC[C@@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)nccc32)C1
3.0,Recruiting,EFO_0007160,autoimmune thrombocytopenic purpura,CHEMBL3702854,RILZABRUTINIB,BTK,CC(C)(/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)N1CCN(C2COC2)CC1
3.0,Terminated,EFO_0003929,relapsing-remitting multiple sclerosis,CHEMBL4072833,EVOBRUTINIB,BTK,C=CC(=O)N1CCC(CNc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1
2.0,Recruiting,EFO_0000096,neoplasm of mature B-cells,CHEMBL4650338,EDRALBRUTINIB,BTK,CC#CC(=O)N1CC[C@@H](n2cc(-c3ccc(Oc4c(F)cccc4F)cc3)c3c(N)n[nH]c(=O)c32)C1
2.0,Completed,EFO_0000095,chronic lymphocytic leukemia,CHEMBL4071161,TIRABRUTINIB,BTK,CC#CC(=O)N1CC[C@@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1
2.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL3301600,SPEBRUTINIB BESYLATE,BTK,C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1.O=S(=O)(O)c1ccccc1
2.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL3301625,SPEBRUTINIB,BTK,C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1
2.0,Terminated,EFO_0000685,rheumatoid arthritis,CHEMBL4163691,POSELTINIB,BTK,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3ccoc23)c1
2.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL3900554,BMS-986142,BTK,Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O
2.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL4594348,ELSUBRUTINIB,BTK,C=CC(=O)N1CCC[C@@H](c2ccc(C(N)=O)c3[nH]ccc23)C1
1.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL4297674,BRANEBRUTINIB,BTK,CC#CC(=O)N[C@H]1CCCN(c2c(F)cc(C(N)=O)c3[nH]c(C)c(C)c23)C1
1.0,Completed,MONDO_0007915,systemic lupus erythematosus,CHEMBL3545193,MSC-2364447,BTK,
4.0,,EFO_0000540,immune system disease,CHEMBL1201828,ECULIZUMAB,C5,
4.0,,EFO_0000540,immune system disease,CHEMBL3989986,RAVULIZUMAB,C5,
4.0,,EFO_0004991,Myasthenia gravis,CHEMBL5315048,ZILUCOPLAN SODIUM,C5,
4.0,,HP_0002243,Protein-losing enteropathy,CHEMBL4298086,POZELIMAB,C5,
3.0,Completed,EFO_0001645,coronary artery disease,CHEMBL2107979,PEXELIZUMAB,C5,
3.0,Completed,EFO_0004991,Myasthenia gravis,CHEMBL4298207,ZILUCOPLAN,C5,
3.0,Withdrawn,EFO_0007292,Guillain-Barre syndrome,CHEMBL4594316,CROVALIMAB,C5,
3.0,Recruiting,EFO_0004991,Myasthenia gravis,CHEMBL4297722,CEMDISIRAN,C5,
3.0,Withdrawn,EFO_0007187,bullous pemphigoid,CHEMBL4297928,NOMACOPAN,C5,
3.0,Recruiting,HP_0000999,Pyoderma,CHEMBL2109636,VILOBELIMAB,C5,
2.0,Completed,EFO_0001365,age-related macular degeneration,CHEMBL4298012,TESIDOLUMAB,C5,
2.0,Terminated,EFO_0002689,antiphospholipid syndrome,CHEMBL3990025,OLENDALIZUMAB,C5,
